1887

Journal of General Virology header logo

Volume 75, Issue 11

Persistence of Replicating Coxsackievirus B3 in the Athymic Murine Heart is Associated with Development of Myocarditic Lesions Free

Abstract

Coxsackievirus B3 (CVB3)-induced myocarditis was studied in euthymic (/+) and athymic (/) C3H/ HeN (H-2) mice. Mice were inoculated intra-peritoneally with 10 p.f.u. of CVB3 (Nancy strain) and sacrificed at intervals up to 92 days post-inoculation (p.i.). Viraemia peaked at day 2 to 3 p.i. and ceased at day 5 to 7 p.i. in a synchronized manner in both sets of mice. Very few infectious particles were detected in the blood of / mice after day 14 p.i. In / mice, CVB3 persisted in myocardial tissue with constant titres between 2·7 ± 1·9 × 10 and 7·6 ± 5·2 × 10 p.f.u./mg from day 3 to 92 p.i., which were comparable to those of /+ mice in the acute phase. In /+ mice, the virus was recovered from all animals examined by day 11 p.i. and from three out of 13 mice between days 14 and 21 p.i., yet no virus was recovered from /+ mice at day 42 p.i. In / mice, sense and antisense RNA for CVB3 was detected in the myocardial tissue up to day 42 p.i. by hybridization and up to day 92 p.i. by reverse transcriptase-PCR. Neither sense nor antisense RNA was detected after day 21 p.i. in /+ mice with the same techniques. Myocardial tissue damage was analysed morphologically. At day 92 p.i., the area of myocardial injury peaked at 23% of the section in / mice. In contrast, less than 0·6% of tissue sections contained lesions in /+ mice. A neutralizing antibody response to CVB3 was observed in both / and /+ mice. The mean titre of neutralizing antibody was significantly higher at day 21 p.i. in /+ mice, but similar at day 42 p.i. with / and /+ mice. Perforin-producing natural killer-like cells, which are considered to play an important role in causing acute myocarditic lesions in immunocompetent mice, were found in the lesions of / mice persistently infected with CVB3. Prolonged tumour necrosis factor- mRNA synthesis detected in / mice appears to reflect the continuous activation of macrophages, which extend phagocytic reactions to virus-infected myocytes. These immunological results suggested that the host immune response devoid of antigen-specific T cell function is not sufficient to terminate CVB3 infection in / mice. Also, it appears that competent cellular immunity, on the whole, plays a role in curing rather than in aggravating myocarditis in /+ mice. In conclusion, our results indicate that the presence of replicating CVB3 is an important factor in the development of myocarditic lesions in C3H/HeN mice.

  • Received:
  • Accepted:
  • Published Online:
© The Journal of General Virology 1994
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-11-2911
1994-11-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/11/JV0750112911.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-11-2911&mimeType=html&fmt=ahah

References

  1. Bowles N. E., Richardson P. J., Olsen E. G. J., Archard L. C. 1986; Detection of coxsackie-B-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet i:1120–1123
     [Google Scholar]
  2. Bowles N. E., Rose M. L., Taylor P., Banner N. R., Morgan-Capner P., Cunningham L., Archard L. C., Yacoub M. H. 1989; End-stage dilated cardiomyopathy; persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation 80:1128–1136
     [Google Scholar]
  3. Burch G. E., Sun S. C., Colcolough H. L., Sohal R. S., Depasquale N. P. 1967; Coxsackie B viral myocarditis and valvulitis identified in routine autopsy specimens by immuno-fluorescent techniques. American Heart Journal 74:13–23
     [Google Scholar]
  4. Burch G. E., Sun S. -C., Chu K. -C., Sohal R. S., Colcolough H. L. 1968; Interstitial and coxsackievirus B myocarditis in infants and children. Journal of the American Medical Association 203:55–62
     [Google Scholar]
  5. Chow L. H., Gauntt C. J., Mcmanus B. M. 1991; Differential effects of myocarditic variants of coxsackievirus B3 in inbred mice. Laboratory Investigation 64:55–64
     [Google Scholar]
  6. Chow L. H., Beisel K. W., Mcmanus B. M. 1992; Enteroviral infection of mice with severe combined immunodeficiency. Laboratory Investigation 66:24–31
     [Google Scholar]
  7. Fransen L., Müller R., Marmenout A., Tavernier J., Van Der Heyden J., Kawashima E., Chollet A., Tizard R., Van Heuverswyn H., Van Vliet A., Ruysschaert M. -R., Fiers W. 1985; Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Research 13:4417–4429
     [Google Scholar]
  8. Grist N. R., Bell E. J. 1973; A six-year study of coxsackievirus B infection in heart disease. Journal of Hygiene 73:165–172
     [Google Scholar]
  9. Henke A., Mohr C., Sprenger H., Graebner C., Stelzner A., Nain M., Gemsa D. 1992; Coxsackievirus B3-induced production of tumor necrosis factor-α, IL-β, and IL-6 in human monocytes. Journal of Immunology 148:2270–2277
     [Google Scholar]
  10. Hillman K., Shapira-Nahor O., Blackburn R., Hernandez D., Golding H. 1991; A polymer containing peptide sequence can stimulate T-cell-independent IgG antibody production in vivo. Cellular Immunology 134:1–3
     [Google Scholar]
  11. Huber S., Lodge P. A. 1984; Coxsackievirus B-3 myocarditis in BALB/c mice; evidence for autoimmunity to myocyte antigens. American Journal of Pathology 116:21–29
     [Google Scholar]
  12. Jin O., Sole M. J., Butany J. W., Chia W. -K., Mclaughin P. R., Liu P., Liew C. -C. 1990; Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 82:8–16
     [Google Scholar]
  13. Kandolf R., Ameis D., Kirschner P., Canu A., Hofschneider P. H. 1987; In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proceedings of the National Academy of Sciences U.S.A: 846272–6276
     [Google Scholar]
  14. Kandolf R., Kirschner P., Ameis D., Canu A., Erdmann E., Schultheiss H. -P., Kemkes B., Hofschneider P. H. 1988; . In New Concepts in Viral Heart Disease pp 337–348 Schultheiss H. -P. Edited by Berlin: Springer-Verlag;
     [Google Scholar]
  15. Khatib R., Probert A., Reyes M. P., Khatib G., Chason J. L. 1987; Mouse strain-related variation as a factor in the pathogenesis of coxsackievirus B3 murine myocarditis. Journal of General Virology 68:2981–2988
     [Google Scholar]
  16. Kingston R. E. 1991; Preparation and analysis of RNA: guanidium methods for total RNA preparation. In Current Protocols in Molecular Biology 1 supplement 14 4.2 Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. Edited by New York: John Wiley;
     [Google Scholar]
  17. Klingel K., Hohenadl C., Canu A., Albrecht M., Seemann M., Mall G., Kandolf R. 1992; Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proceedings of the National Academy of Sciences U.S.A: 89314–318
     [Google Scholar]
  18. Koontz C.II Ray C. G. 1971; The role of coxsackie group B virus infections in sporadic myopericarditis. American Heart Journal 82:750–758
     [Google Scholar]
  19. Leslie K., Blay R., Haisch C., Lodge A., Weller A., Huber S. 1989; Clinical and experimental aspects of viral myocarditis. Clinical Microbiology Reviews 2:191–203
     [Google Scholar]
  20. Loudon R. P., Moraska A. F., Huber S. A., Schwimmbeck P., Schultheiss P. 1991; An attenuated variant of coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo. Journal of Virology 65:5813–5819
     [Google Scholar]
  21. Morgan-Capner P., Mcsorley R. C., Daly K., Pattison J. R. 1984; Virus investigations in heart muscle disease. In Viral Heart Disease pp 99–115 Bolte H. -D. Edited by Berlin: Springer-Verlag;
     [Google Scholar]
  22. Okada I., Matsumori A., Kawai C., Yodoi J., Tracy S. 1990; The viral genome in experimental murine coxsackievirus B3 myocarditis: a Northern blotting analysis. Journal of Molecular Cell Cardiology 22:999–1008
     [Google Scholar]
  23. Petitjean J., Kopecka H., Freymuth F., Langlard J. M., Scanu P., Galateau F., Bouhour J. B., Ferriere M., Charbonneau P., Komajda M. 1992; Detection of enteroviruses in endomyocardial biopsy by molecular approach. Journal of Medical Virology 37:76–82
     [Google Scholar]
  24. Sato S., Burke A., Benson W., Mergner W., Tracy S., Gauntt C., Virmani R. 1993; The pathology of murine coxsackievirus B3 myocarditis: an in situ hybridization study. Cardiovascular Pathology 2:107–115
     [Google Scholar]
  25. Schmidt N. J., Magoffin R. L., Lennette E. H. 1973; Association of group B coxsackieviruses with cases of pericarditis, myocarditis, or pleurodynia by demonstration of immunoglobulin M antibody. Infection and Immunity 8:341–348
     [Google Scholar]
  26. Schnittman S. M., Psallidopoulos M. C., Clifford-Lane H., Thompson L., Baseler M., Massari F., Fox C. H., Salzman N. P., Fuaci A. S. 1989; The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245:305–309
     [Google Scholar]
  27. Schnurr D. P., Schmidt N. J. 1984; Coxsackievirus B3 persistence and myocarditis in NFR nu/nu and μl/nu mice. Medical Microbiology and Immunology 173:1–7
     [Google Scholar]
  28. Schnurr D. P., Schmidt N. J. 1988; Persistent infections. In Coxsackieviruses: A General Update, pp 181–201 Bendinelli M., Friedman H. Edited by New York: Plenum Press;
     [Google Scholar]
  29. Schnurr D. P., Cao Y., Schmidt N. J. 1984; Coxsackievirus B3 persistence and myocarditis in N:NIH(S) II nu/nu and + /nu mice. Journal of General Virology 65:1197–1201
     [Google Scholar]
  30. Seko Y., Shinkai Y., Kawasaki A., Yagita H., Okumura K., Takaku F., Yazaki Y. 1991; Expression of perforin in infiltrating cells in murine hearts with acute myocarditis caused by coxsackievirus B3. Circulation 84:788–795
     [Google Scholar]
  31. Sherry B., Li X. -Y., Tyler K. L., Cullen J. M., Virgin H. W.IV 1993; Lymphocytes protect against and are not required for reovirus-induced myocarditis. Journal of Virology 67:6119–6124
     [Google Scholar]
  32. Smith W. G. 1970; Coxsackie B myopericarditis in adults. American Heart Journal 80:34–46
     [Google Scholar]
  33. Sutton G. C., Tobin J. R., Fox R. T., Freeark R. J., Driscoll J. F. 1963; Study of the pericardium and ventricular myocardium. Journal of the American Medical Association 185:786–788
     [Google Scholar]
  34. Sutton G. C., Harding H. B., Trueheart R. P., Clark H. P. 1967; Coxsackie B4 myocarditis in an adult: successful isolation of virus from ventricular myocardium. Aerospace Medicine 38:66–69
     [Google Scholar]
  35. Tishon A., Eddleston M., Delatorre J. C., Oldstone M. B. A. 1993; Cytotoxic T lymphocytes cleanse viral gene products from individually infected neurons and lymphocytes in mice persistently infected with lymphocytic choriomeningitis virus. Virology 197:463–467
     [Google Scholar]
  36. Tracy S., Liu H. -L., Chapman N. M. 1985; Coxsackievirus B3: primary structure of the 5′ non-coding and capsid protein-coding regions of the genome. Virus Research 3:263–270
     [Google Scholar]
  37. Tracy S., Chapman N. M., Mcmanus B. M., Pallansch M. A., Beck M. A., Carstens J. 1990; A molecular and serologic evaluation of enteroviral involvement in human myocarditis. Journal of Molecular Cell Cardiology 22:403–414
     [Google Scholar]
  38. Weiss L. M., Movahed L. A., Billingham M. E., Cleary M. L. 1991; Detection of coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction. American Journal of Pathology 138:497–503
     [Google Scholar]
  39. Woodruff J. F. 1979; Lack of correlation between neutralizing antibody production and suppression of coxsackievirus B-3 replication in target organs: evidence for involvement of mononuclear inflammatory cells in host defence. Journal of Immunology 123:31–36
     [Google Scholar]
  40. Woodruff J. F. 1980; Viral myocarditis. American Journal of Pathology 101:426–484
     [Google Scholar]
  41. Woodruff J. F., Woodruff J. J. 1974; Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease. Journal of Immunology 113:1726–1734
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-11-2911
Loading
Persistence of Replicating Coxsackievirus B3 in the Athymic Murine Heart is Associated with Development of Myocarditic Lesions
J. Gen. Virol. 75, 2911 (1994); https://doi.org/10.1099/0022-1317-75-11-2911
/content/journal/jgv/10.1099/0022-1317-75-11-2911
/content/journal/jgv/10.1099/0022-1317-75-11-2911
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error